An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-β signalling
2008 · The EMBO Journal · 54 citations
https://doi.org/10.1038/emboj.2008.218
H
Hiroaki Ikushima
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
3.0K
Citations
14
h-index
17
i10-index
Hiroaki Ikushima is an academic researcher from The University of Tokyo. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics & TGF-β signaling in diseases. The author has an h-index of 14, co-authored 53 publications.
ORCID: 0000-0002-7053-2841Papers by this author
worksRB1CC1 Protein Positively Regulates Transforming Growth Factor-β Signaling through the Modulation of Arkadia E3 Ubiquitin Ligase Activity
2011 · Journal of Biological Chemistry · 35 citations
https://doi.org/10.1074/jbc.m111.227561
Oligodendrocyte Transcription Factor 1 (Olig1) Is a Smad Cofactor Involved in Cell Motility Induced by Transforming Growth Factor-β
2013 · Journal of Biological Chemistry · 24 citations
https://doi.org/10.1074/jbc.m113.480996
Clinical utility of comprehensive genomic profiling in non-small cell lung cancer: An analysis of a nation-wide database
2025 · Lung Cancer · 6 citations
https://doi.org/10.1016/j.lungcan.2025.108099
Transdifferentiation of cervical squamous cell carcinoma with ERBB2 amplification to adenocarcinoma: whole genome sequence analysis and successful control by anti-HER2 therapy
2023 · BJC Reports · 1 citations
https://doi.org/10.1038/s44276-023-00015-9
1205P A retrospective machine learning-based analysis of nationwide cancer CGP data across cancer types to identify features associated with recommendation of mutation-based therapy
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.2134
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat